Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg / day) in a Q.I.D. regimen

Autor: Chadwick, D.W, Betts, T.A, Boddie, H.G, Crawford, P.M, Lindstrom, P, Newman, P.K, Soryal, I, Wroe, S, Holdich, T.A.H
Zdroj: In Seizure: European Journal of Epilepsy March 2002 11(2):114-123
Databáze: ScienceDirect
Externí odkaz: